☰

Stephanie L. Matheson, Ph.D. - Publications

Affiliations: 
2003 McGill University, Montreal, QC, Canada 
Area:
Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Matheson S, Qiu Q, Brahimi F, Dudouit F, Banerjee R, Rachid Z, Jean-Claude BJ. [Combi-molecules: a global approach towards better chemoselectivity and chemosensitivity]. Bulletin Du Cancer. 91: 911-5. PMID 15634632  0.706
2004 Matheson SL, McNamee JP, Wang T, Alaoui-Jamali MA, Tari AM, Jean-Claude BJ. The combi-targeting concept: dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo. The Journal of Pharmacology and Experimental Therapeutics. 311: 1163-70. PMID 15358812 DOI: 10.1124/Jpet.104.071977  0.719
2004 Matheson SL, Brahimi F, Jean-Claude BJ. The combi-targetinG concept: intracellular fragmentation of the binary epidermal growth factor (EGFR)/DNA targeting "combi-triazene" SMA41. Biochemical Pharmacology. 67: 1131-8. PMID 15006549 DOI: 10.1016/J.Bcp.2003.10.035  0.685
2003 Matheson SL, McNamee JP, Jean-Claude BJ. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41. Cancer Chemotherapy and Pharmacology. 51: 11-20. PMID 12497201 DOI: 10.1007/S00280-002-0525-4  0.715
2003 Qiu Q, Dudouit F, Matheson SL, Brahimi F, Banerjee R, McNamee JP, Jean-Claude BJ. The combi-targeting concept: a novel 3,3-disubstituted nitrosourea with EGFR tyrosine kinase inhibitory properties. Cancer Chemotherapy and Pharmacology. 51: 1-10. PMID 12497200 DOI: 10.1007/S00280-002-0524-5  0.718
2003 Matheson SL, Mzengeza S, Jean-Claude BJ. Synthesis of 1-[4-(m-tolyl)amino-6-quinazolinyl]-3-[14C]-methyl triazene: a radiolabeled probe for the combi-targeting concept Journal of Labelled Compounds and Radiopharmaceuticals. 46: 729-735. DOI: 10.1002/Jlcr.713  0.515
2002 Brahimi F, Matheson SL, Dudouit F, McNamee JP, Tari AM, Jean-Claude BJ. Inhibition of epidermal growth factor receptor-mediated signaling by "Combi-triazene" BJ2000, a new probe for Combi-Targeting postulates. The Journal of Pharmacology and Experimental Therapeutics. 303: 238-46. PMID 12235257 DOI: 10.1124/Jpet.102.039099  0.738
2001 Matheson SL, McNamee J, Jean-Claude BJ. Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumor targeting strategy. The Journal of Pharmacology and Experimental Therapeutics. 296: 832-40. PMID 11181914  0.744
Show low-probability matches.